Prevalence of erectile dysfunction (ED) increases with age and is associated with chronic comorbidities, such as diabetes and hypertension. Even so, ED is underdiagnosed and undertreated. This study investigated the effect of raising awareness of ED diagnosis and treatment in a community setting by physicians' education. Thirty-nine primary care physicians participated in lectures by a trained sexologist, and 20 of them also received computerized lists of their high-risk patients. We matched a control group of 39 primary care physicians who did not receive the intervention; we thus followed 1959 patients in both intervention groups and 1903 patients in the control group. During the period of 6 months before the intervention and 6 months after the intervention, no significant differences were found between the groups in diagnosis of new ED patients, in phosphodiesterase-5 inhibitor prescriptions or in referrals to urologists. We therefore suggest that sporadic lectures and computerized patient lists do not significantly affect the physician's behavior.
Introduction
Erectile dysfunction (ED) is an age-related disease with increased prevalence when accompanied by various medical conditions and medications. [1] [2] [3] Diabetes and hypertension are the two major-risk factors for ED, as are the medical treatments related to these diseases. Such patients are prone to ED by more than 50% after age adjustment. 1, 4 In contrast, ED might also be the presenting symptom of other serious medical conditions, such as dyslipidemia, diabetes, hypertension, depression or anxiety. Thus, it is well established that inquiring about ED is an important part of the medical history. 5 Primary care physicians (PCPs) encounter many such patients in common practice; 1, 6 however, ED is not always diagnosed or even discussed during the medical interview. Physicians' attention to such patients may improve ED diagnosis, and thus improve patients' satisfaction and provide an important tool in medical diagnosis. Moreover, ED diagnosis and treatment may lead to improvement in patients' compliance with other comorbidities. 7 Maccabi Healthcare Services is Israel's second largest health maintenance organization (HMO), with over 1.8 million members nationwide and fully computerized patients' medical records. In this study we sought to evaluate whether a short course for physicians and identification of patients using the computerized database could help improve ED diagnosis and treatment rate in high-risk patients. During the period of the study, physicians and patients were exposed to mass media campaigns and various medical publications on the issue.
Methods
A random sample of 40 PCPs attending local CME courses was selected from Maccabi Healthcare Services central district. In June 2007, these physicians were invited to three lectures on ED. The lectures were given by an experienced sexologist. During the lecture, they discussed issues regarding ED epidemiology, the importance of identifying these patients, ways to approach patients about the topic and also given a brief overview about available treatments. Of the 40 physicians in the intervention group, we randomly selected 20 physicians, who were given a list of their own patients, who may be considered to be at high risk for ED. All these patients had no earlier diagnosis of ED and did not receive any phosphodiesterase-5 inhibitor (PDE5-inh) drugs in the previous 6 months. The list was on the basis of the computerized database and medical registries, and was composed of male patients, who were at least 55-year-old, with hypertension or uncontrolled diabetes. Uncontrolled diabetics were defined as such if their last glycosilated hemoglobin (HbA1c) was above 8% and were of at least 7 years of duration. Hypertensive patients had had the condition and were under treatment for it for at least 5 years of duration and treatment. All 40 physicians received two telephone reminders during the followup period from the investigator. A control group was matched to the intervention group by age, number of ED high-risk patients and percentage of patients that were prescribed with PDE5-inh drugs. All medical considerations and follow-up were done solely by the treating physicians in all three groups of physicians. Data analysis compared the 6 months before the intervention (1 January 2007-30 June 2007) with the 6 months after intervention (1 July 2007-31 December 2007). We analyzed differences between the physicians' groups over the two periods. The outcome variables were the number of new ED diagnoses, number of referrals to urologists and number of prescriptions written for PDE5-inh drugs.
Statistical analysis was done once on the patient level, when the dependent and independent variables were related to each patient, and again on the physician level, whereas these variables were related to each physician's patient population. All statistical analysis was done with SPSS 15.0 for Windows r SPSS Inc. The study was approved by the institutional review board and was granted a waiver from signing the participating physicians an informed consent form.
Results
In June 2007, 40 PCPs participated in three lectures. One physician was excluded from the analysis because he was no longer affiliated with the HMO. So for the final analysis, we included 39 physicians in the intervention group and 39 physicians in the control group. A comparison of the intervention vs the control group is described in Table 1 . Twenty physicians from the intervention group were randomly selected and received a computer-generated list of ED high-risk patients. In a subanalysis comparing the two intervention groups, there were no significant differences in any of the outcome variables. Therefore, we completed the analysis between both the intervention groups vs the control group, with 1959 and 1903 patients in each group, respectively.
In assessing the differences between intervention and control groups on the patient level, the dependent and independent variables were related to each patient. During the period before the intervention, the number of new diagnoses of ED was 1.07 vs 1.05% in the intervention and control groups, respectively, P ¼ 0.95. During the period after the intervention, the number of new diagnoses of ED was 1.0 vs 1.2% in the intervention and control groups, respectively, P ¼ 0.57. Similarly, the number of new patients, who received prescriptions for PDE5-inh medications, did not differ significantly in the two groups in both periods (2.1 vs 2.1%, P ¼ 0.98 before the intervention and 1.6 vs 2.2%, P ¼ 0.19 after the intervention, respectively). There was also no significant change in the number of patient referrals to urologists for consultation (25.8 vs 24.6%, P ¼ 0.418 and 27.3 vs 24.9%, P ¼ 0.088, respectively).
Backward logistic regression to analyze predictors for new ED diagnosis showed the significant effect of patients' age of 65-74 and 55-64 years vs the age group of 75 þ years (odds ratio (OR) 2.348, In assessing differences between the intervention and control groups, 35 physicians in each group treated at least two patients each who met the inclusion criteria. There was no significant difference in the rates of new ED diagnosis between the intervention and the control groups before the intervention (1.12%±2.05 and 0.66%±1.19, P ¼ 0.249, respectively) or after the intervention (1.34% ± 1.60 and 1.02% ± 4.30, P ¼ 0.682, respectively).
We did not observe any difference in new PDE5-inh prescriptions between both groups in both periods nor in the number of referrals to urologists.
Multiple linear regression did not show any significant changes among the physician groups in terms of the number of new ED diagnoses, new PDE5-inh prescriptions or number of referrals to urologists.
Discussion
Erectile dysfunction is very common in primary care settings, especially among patients with other comorbidities, such as diabetes or hypertension. [1] [2] [3] Diagnosis and treatment of ED is known to increase patients' satisfaction and may even lead to the improvement in patients' compliance with other comorbidities. 7 This study investigated the possibility of increasing the rates of ED diagnosis and treatment following a short course and the use of computerized lists of high-risk patients.
We observed trends of more referrals to urologists for consultation in the intervention group, but more new ED diagnoses in the control group. While analyzing the results, one must take into account foreign interventions. Such interventions include independent patients and physicians' exposure to a new commercial media campaigns in Israel on MayJune 2007 with the aim of raising the awareness towards ED, and studies that were published during and around the study period regarding rare, severe side effects of PDE5-inh medications. 8, 9 However, these processes most probably acted in both groups in both ways, and thus it is hard to assess their influence over theses variables. ED diagnosis and medical treatment correlate with the patients' age, so that younger patients had a greater chance to be diagnosed with ED and to be given prescriptions for PDE5-inh. Such trends were also observed in studies with even younger male populations, as young adult males are increasingly prescribed with PDE5-inh. Uncontrolled diabetic patients of more than 7 years of duration had a threefold more likelihood to receive PDE5-inh prescription vs patients with other health conditions (hypertension of at least 5 years and diabetes of o7 years). The reason might be related to the duration of each disease or the influence of each on ED.
Although there was no significant difference in new ED diagnosis between the study group and the intervention groups both before and after the intervention, there was an increase in the number of new diagnoses in both the groups. This may be related to the independent mass media campaign that took place parallel to the study, which may have affected both groups.
There were also several important limitations to the study that should be noted. Although these were chronic patients with long-standing risk, ED might have not been developed yet, as well as the patients might have not seen the physician within the follow-up period of 6 months. A longer follow-up period could have increased the chances of diagnosis and treatment.
Although we followed more than 3800 patients, the study sample (20 physicians and 20 physician controls) was relatively small. Future studies are required to examine the study hypothesis in larger physician population.
As in the HMO there is an active capitation, where incentives correlate with chronic treatments; we do not assume a bias in ED underdiagnosis or undertreatment. Moreover, the study showed no significant difference between both study groups.
In both study analyses, we did not observe significant changes between the intervention and the control groups. We thus suggest that sporadic lectures and computerized patient lists have only a minor affect on the physicians' behavior. Future studies are required to investigate different methods of increasing the awareness of ED such as: the effect of longer educational interventions, combination of mass media campaigns or the effect of a continuous sexologist consultation to PCPs.
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